In our study transcription factor, FOXP3 promoter methylation and expression were studied and analyzed in breast cancer patients of the northern region of India using methylation-specific PCR, real-time PCR, and immunohistochemistry to assess its role as a potential biomarker. This evidence concerns the gene FOXP3 and breast carcinoma.